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Abstract
Background: Photodegradation of certain vitamins such as riboflavins, carotinoids, tocopherol,
and folate has been well-documented. Previous observations suggest that ultraviolet (UV) radiation
may cause folate deficiency. This is of great importance since folate deficiency is also known to be
linked with the development of neural tube defects. To investigate the influence of UVA radiation
on serum folate levels in vivo, we conducted a two-group randomised controlled trial on healthy
subjects.
Material and methods: Twenty-four healthy volunteers with skin type II were enrolled into the
study. Eight volunteers of the study population were randomly assigned to the control group. UVA
irradiation was administered with an air-conditioned sunbed. Blood samples were taken from all
volunteers at baseline (T1), 30 min after the first UVA exposure (T2), and at the end of the study
24 h after the sixth UV exposure (T3). The volunteers had two UVA exposures weekly within three
weeks (cumulative UVA dose: 96 J/cm2). Volunteers of the control group had no UVA exposures.
Serum folate was analysed with an automated immunoassay system.
Results: At all times of blood collection the differences between serum folate levels were
insignificant (P > 0.05), except of the non-exposed controls at T2 (P < 0.05). We did not observed
significant differences of folate levels between UVA exposed and non-exposed volunteers (P >
0.05).
Conclusions: Our data suggest that both single and serial UVA exposures do not significantly
influence serum folate levels of healthy subjects. Therefore, neural tube defects claimed to occur
after periconceptual UVA exposure are probably not due to UVA induced folate deficiency.
Background
Folate, the conjugated form of folic acid, is an essential
nutrient that is required for nucleotide respective DNA
biosynthesis. Apart from macrocytic megaloblastic ane-
mia folate deficiency has also been shown to produce
multiple fetal anomalies in nonhuman mammals. More-
over, it has recently been confirmed that there is a con-
nection between defective folate metabolism, neural
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impaired spermatogenesis in humans [1,2]. Folate catab-
olism and simultaneous folate deficiency has been ob-
served in various conditions, such as pregnancy,
alcoholism, drug use (e.g., methotrexate), and malnutri-
tion. Photodegradation of certain vitamins such as ribo-
flavins, carotinoids, tocopherol, and folate has been well-
documented [3–5]. Photolysis of folate may be signifi-
cant, especially when serum is exposed in vitro to ultra-
violet (UV) radiation. In one study, published in the
journal Science[6], it has been reported that fair-skinned
patients undergoing photochemotherapy for dermato-
logical conditions have low serum folate concentrations,
suggesting that photolysis may also occur in vivo. Be-
sides, neural tube defects (NTD) have been found associ-
ated with sunbed exposures during the first weeks of
pregnancy [7]. Nevertheless, phototherapy is generally
recommended by dermatologists as safe to use in preg-
nant women [8]. Since there is a lack of controlled stud-
ies in this field, we conducted a two-group randomised
controlled trial investigating serum folate levels of




Twenty-four healthy volunteers with skin type II [9]
were subsequently recruited. Exclusion criteria includ-
ed: pregnancy, abnormal diets, drug use, and UV expo-
sure within the last two months prior to the study. All
volunteers gave informed consent for participation in the
study. Randomised allocation of two groups was per-
formed by asking the volunteers to throw dice without
knowing the underlying allocation criteria (nos 1–3: ex-
posed group; nos 4–6: non-exposed group). Thus eight
volunteers of the study population were randomly as-
signed to the control group. The study was conducted in
a university dermatological department during winter.
UV source and dosimetry
An air-conditioned sunbed (JK-Products GmbH, Wind-
hagen, Germany) was used fitted with 42 Solarium Plus
R1-12-100 W fluorescence lamps (Wolff System AG,
Riegel, Germany). Before the beginning of the investiga-
tion the spectral output of the lamps was measured with
a calibrated MED 2000 spectroradiometer (Opsira Gm-
bH, Weingarten, Germany). The integrated irradiance
measured at skin level was 17.5 mW/cm2 for UVA and
0.09 mW/cm2 UVB. The emission spectrum of the fluo-
rescence lamp is shown in Figure 1. UVA irradiance was
routinely measured each exposure session with UV-ME-
TER radiometer (Waldmann, Willingen-Schwenningen,
Germany). The volunteers had two UVA exposures week-
ly within three weeks, the controls had no exposures. The
UVA dose of each exposure session was 16 J/cm2, and
the cumulative UVA dose after 6 exposures was 96 J/
cm2.
Blood collection and determination of folate
Blood samples were taken from the volunteers in the
morning at baseline (T1), 30 min after the first UV expo-
sure (T2), and at the end of the study 24 h after the sixth
UV exposure (T3). Determination of serum folate was
performed using the automated immunoassay system
AD VIA Centaur® IS (Bayer Diagnostics, Fernwald, Ger-
many). Normal range of serum folate is 3–20 ng/ml with
the assay used.
Statistics
We used the SPSS 10.0 for Windows. Analysis of distri-
bution was made by the Kolmogorov-Smirnov-test. For
comparison of paired and independent samples by nor-
mal distribution the 2-tailed Student's t-test was used
and for comparison of paired samples by non-normal
distribution the Wilcoxon test. Differences were consid-
ered significant when P < 0.05.
Results and Discussion
A homogenous distribution of sex and age was found for
the UV exposed volunteers and non-exposed controls (P
> 0.05). Means ± SD of serum folate levels are listed in
Table 1. For all volunteers serum folate levels were within
the normal range at T1, T2, and T3. At all times of blood
collection the differences between serum folate levels
were insignificant for UV exposed as well as non-exposed
volunteers (P > 0.05), except of the non-exposed con-
trols at T2 (P < 0.05). However, this was certainly not of
clinical relevance. We did not observe significant differ-
Figure 1
Spectral irradiance of the fluorescence lamp used in this
study.
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posed volunteers (P > 0.05).
The protective role of folate in preventing NTD is well es-
tablished [9]. Jablonski and Chaplin [1] recently hypoth-
esized that highly melanised skin protecting against UV
induced photolysis of folate is of great importance for in-
dividual reproductive success, and that folate photolysis
may, especially in fair-skinned women, precipitate a
folate deficiency sufficient to cause a neural tube defect
during the first weeks of pregnancy. Therefore it has
been suggested to avoid periconceptual UV exposure [2].
It has to be stressed, however, that folate deficiency is
common in pregnant women and may arise both from in-
adequate dieatary folate and from increased utilization
of the vitamin during pregnancy [4]. In fact, low preva-
lences of severe folate deficiency and NTD have been ob-
served in native Africans and African Americans [11,12].
Branda and Eaton [6] found that exposure of human
plasma in vitro to solar-simulated radiation causes 30–
50% loss of folate within 60 min. They also conducted an
in vivo trial on 10 fair-skinned Scandinavians undergo-
ing photochemotherapy because of various skin diseases
which have not been detailed in their paper. However,
one may assume that it predominantly concerned psoria-
sis patients. They were treated with methoxalen and
UVA radiation (4.5 to 9.5 J/cm2) once or twice per week.
The time of blood collection was after 3 to 13.5 months
after starting photochemotherapy. Baseline folate levels
were not determined. The authors found that serum
folate levels of the patients were significantly lower than
those of 64 healthy controls. Nevertheless, the folate lev-
els of the patients were not within the abnormal range.
Possible drug interactions (e.g., methoxalen, methotrex-
ate) and disease-associated factors (e.g., psoriasis and al-
cohol abuse) affecting folate metabolism were not
discussed by the authors [6,13]. Because of the method-
ology and the restrictive description given in Branda and
Eaton's report [6] definitive conclusions can hardly be
drawn from their results.
Lapunzina [7] observed three patients with NTD whose
mothers had sunbed exposures during the first weeks of
their pregnancies. All three mothers were young and
healthy. Although folate deficiency of the mothers was
not proved, the author speculated that sunbed exposure
may have caused teratogenesis in these three patients.
Based on epidemiological data Van Rootselaar [14] also
suggests that UV radiation may cause NTD in embryos of
exposed mothers. Furthermore, Lapunzina [7] hypothe-
sized that heat respective hyperthermia-related effects
could possibly cause NTD. This was also postulated by
Milunsky et al. [15], who found an increased risk for NTD
among offspring of women exposed to heat in form of hot
tub, sauna, or fever during early pregnancy.
To study photolysis of serum folate relatively independ-
ent from photoprotection due to pigmentation only vol-
unteers with skin type II were included in our study. In
comparison to Branda and Eaton [6] we used higher sin-
gle UVA doses. Studies on UVB-induced alterations of
serum folate levels has not been conducted. In vitro, var-
ious folate vitamers (poylyglutamates) may be detected
using fluorescence detection at UV excitation of different
wavelenght, e.g. 290 nm or 360 nm. In Figure 2 is shown
that these folate vitamers can also be characterized by
different absorbance spectra using high-performance
liquid chromatography with a UV diode array detection
system [16,17]. Apart from spectral absorbance of certain
folate vitamers within the UVA range there is also con-
siderable absorbance within the UVB and UVC range
(Fig. 2). However, UVC does not form a part of solar UV
radiation on earth, and because of its minor dermal pen-
etration depth UVB radiation has probably no significant
influence on serum folate levels [18]. Based on our study
we cannot exclude that higher single and/or cumulative
UVA doses than those used in this trial, or that UVB ra-
diation induce folate catabolism. This should be investi-
gated in further controlled studies. In future studies, it
would be also of interest to include other parameters of
folate catabolism such as red cell folate and genetic poly-
morphism.
Table 1: Baseline characteristics of the 24 volunteers and means ± SD of serum folate levels (ng/ml) before (T1) and after (T2; T3) UVA 
exposure
Volunteers Sex female (f); 
male (m)
Mean age years T1 T2 T3
UV exposed 11 f; 5 m 25.5 (19–39)* 10.1 ± 3.1 (6.3–20)* 10.4 ± 3 (6.1–17)* 10.6+3.3 (5.9–17.2)*
Non-exposed 5 f; 3 m 25.9 (18–36)* 11.6 ± 3.5 (7.2–30)* 12.9 ± 3.9 (8.3–32)* 11 ± 3.1 (6.5–20.2)*
*range
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Our data suggest that both single and serial UVA expo-
sures do not significantly influence serum folate levels in
vivo. Based on these results, we conclude that NTD
claimed to occur after periconceptual UVA exposure are
probably not due to UVA induced folate catabolism.
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